119 related articles for article (PubMed ID: 8183446)
1. Haemorrhagic pituitary tumours.
Lazaro CM; Guo WY; Sami M; Hindmarsh T; Ericson K; Hulting AL; Wersäll J
Neuroradiology; 1994; 36(2):111-4. PubMed ID: 8183446
[TBL] [Abstract][Full Text] [Related]
2. Pituitary adenomas: possible role of bromocriptine in intratumoral hemorrhage.
Yousem DM; Arrington JA; Zinreich SJ; Kumar AJ; Bryan RN
Radiology; 1989 Jan; 170(1 Pt 1):239-43. PubMed ID: 2909102
[TBL] [Abstract][Full Text] [Related]
3. Computed tomography of hemorrhage in a pituitary adenoma without apoplexy.
Parikh VP; Talwar I
J Comput Tomogr; 1988 Jul; 12(3):187-9. PubMed ID: 3168536
[TBL] [Abstract][Full Text] [Related]
4. Relationship between expression of vascular endothelial growth factor and intratumoral hemorrhage in human pituitary adenomas.
Jin Kim Y; Hyun Kim C; Hwan Cheong J; Min Kim J
Tumori; 2011; 97(5):639-46. PubMed ID: 22158497
[TBL] [Abstract][Full Text] [Related]
5. Silent mixed corticotroph and somatotroph macroadenomas presenting with pituitary apoplexy.
Abe T; Taniyama M; Xu B; Ozawa H; Kawamura N; Shimazu M; Sasaki K; Izumiyama H; Kushima M; Kuwazawa J; Sano T; Matsumoto K
Acta Neuropathol; 2001 Nov; 102(5):435-40. PubMed ID: 11699555
[TBL] [Abstract][Full Text] [Related]
6. MRI of pituitary macroadenomas with reference to hormonal activity.
Lundin P; Nyman R; Burman P; Lundberg PO; Muhr C
Neuroradiology; 1992; 34(1):43-51. PubMed ID: 1553037
[TBL] [Abstract][Full Text] [Related]
7. Angiogenesis in pituitary adenomas - relationship to endocrine function, treatment and outcome.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
J Endocrinol; 2000 May; 165(2):475-81. PubMed ID: 10810311
[TBL] [Abstract][Full Text] [Related]
8. Glycoprotein hormone alpha-subunit secretion in prolactinomas and in non-functioning adenomas: relation with the tumour size.
Warnet A; Porsova-Dutoit I; Lahlou N; Seret-Begue D; Lajeunie E; Chanson P; Woimant F; Lot G; Guillausseau PJ; Roger M
Clin Endocrinol (Oxf); 1994 Aug; 41(2):177-84. PubMed ID: 7523001
[TBL] [Abstract][Full Text] [Related]
9. Hemorrhagic pituitary adenomas: clinicopathological features and surgical treatment.
Fraioli B; Esposito V; Palma L; Cantore G
Neurosurgery; 1990 Nov; 27(5):741-7; discussion 747-8. PubMed ID: 2259404
[TBL] [Abstract][Full Text] [Related]
10. Elevated soluble epidermal growth factor receptor level in pituitary adenoma and carcinoma.
Kong YG; Ren ZY; Su CB; Wang RZ; Ma WB; Lian W
Chin Med Sci J; 2004 Sep; 19(3):199-202. PubMed ID: 15506648
[TBL] [Abstract][Full Text] [Related]
11. Impact of subclinical haemorrhage on the pituitary gland in patients with pituitary adenomas.
Kinoshita Y; Tominaga A; Usui S; Arita K; Sugiyama K; Kurisu K
Clin Endocrinol (Oxf); 2014 May; 80(5):720-5. PubMed ID: 24125536
[TBL] [Abstract][Full Text] [Related]
12. Intrapituitary fluid levels following haemorrhage: MRI appearances in 13 cases.
Lenthall RK; Dean JR; Bartlett JR; Jeffree MA
Neuroradiology; 1999 Mar; 41(3):167-70. PubMed ID: 10206158
[TBL] [Abstract][Full Text] [Related]
13. Pituitary adenomas in patients with multiple endocrine neoplasia type 1: a single-center experience in China.
Wu Y; Gao L; Guo X; Wang Z; Lian W; Deng K; Lu L; Xing B; Zhu H
Pituitary; 2019 Apr; 22(2):113-123. PubMed ID: 30637623
[TBL] [Abstract][Full Text] [Related]
14. Pituitary macroadenomas (>3 cm) in young adulthood: Pathologic and proliferative characteristics.
Öngürü Ö; Düz B; Şimşek H; Günal A; Gönül E
Neurol Neurochir Pol; 2015; 49(4):212-6. PubMed ID: 26188936
[TBL] [Abstract][Full Text] [Related]
15. Pituitary apoplexy in non-functioning pituitary adenomas: long term follow up is important because of significant numbers of tumour recurrences.
Pal A; Capatina C; Tenreiro AP; Guardiola PD; Byrne JV; Cudlip S; Karavitaki N; Wass JA
Clin Endocrinol (Oxf); 2011 Oct; 75(4):501-4. PubMed ID: 21521336
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis in pituitary adenomas and the normal pituitary gland.
Turner HE; Nagy Z; Gatter KC; Esiri MM; Harris AL; Wass JA
J Clin Endocrinol Metab; 2000 Mar; 85(3):1159-62. PubMed ID: 10720055
[TBL] [Abstract][Full Text] [Related]
17. The relationship between MRI invasive features and expression of EMMPRIN, galectin-3, and microvessel density in pituitary adenoma.
Zhang Y; He N; Zhou J; Chen Y
Clin Imaging; 2011; 35(3):165-73. PubMed ID: 21513851
[TBL] [Abstract][Full Text] [Related]
18. Clinicopathological characteristics and therapeutic outcomes in thyrotropin-secreting pituitary adenomas: a single-center study of 90 cases.
Yamada S; Fukuhara N; Horiguchi K; Yamaguchi-Okada M; Nishioka H; Takeshita A; Takeuchi Y; Ito J; Inoshita N
J Neurosurg; 2014 Dec; 121(6):1462-73. PubMed ID: 25237847
[TBL] [Abstract][Full Text] [Related]
19. Characteristic location and growth patterns of functioning pituitary adenomas: correlation with histological distribution of hormone-secreting cells in the pituitary gland.
Baik JS; Lee MH; Ahn KJ; Choi HS; Jung SL; Kim BS; Jeun SS; Hong YK
Clin Imaging; 2015; 39(5):770-4. PubMed ID: 26115915
[TBL] [Abstract][Full Text] [Related]
20. Pediatric pituitary adenoma: a series of 42 patients.
Pandey P; Ojha BK; Mahapatra AK
J Clin Neurosci; 2005 Feb; 12(2):124-7. PubMed ID: 15749410
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
